Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

Yellow fever vaccine: comparison of the neurovirulence of new 17D-204 Stamaril™ seed lots and RK 168-73 strain.

Moulin JC, Silvano J, Barban V, Riou P, Allain C.

Biologicals. 2013 Jul;41(4):238-46. doi: 10.1016/j.biologicals.2013.04.005. Epub 2013 Jun 10.

PMID:
23763825
[PubMed - indexed for MEDLINE]
2.

Production of yellow fever 17DD vaccine virus in primary culture of chicken embryo fibroblasts: yields, thermo and genetic stability, attenuation and immunogenicity.

Freire MS, Mann GF, Marchevsky RS, Yamamura AM, Almeida LF, Jabor AV, Malachias JM, Coutinho ES, Galler R.

Vaccine. 2005 Mar 31;23(19):2501-12.

PMID:
15752837
[PubMed - indexed for MEDLINE]
3.

Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.

Monath TP, Soike K, Levenbook I, Zhang ZX, Arroyo J, Delagrave S, Myers G, Barrett AD, Shope RE, Ratterree M, Chambers TJ, Guirakhoo F.

Vaccine. 1999 Apr 9;17(15-16):1869-82.

PMID:
10217584
[PubMed - indexed for MEDLINE]
4.

Molecular and phenotypic analysis of a working seed lot of yellow fever virus 17DD vaccine strain produced from the secondary seed lot 102/84 with an additional passage in chicken embryos.

Marchevsky RS, da Luz Leal M, Homma A, Coutinho ES, Camacho LA, Jabor AV, Galler R, Freire MS.

Biologicals. 2006 Sep;34(3):191-7. Epub 2005 Dec 2.

PMID:
16326110
[PubMed - indexed for MEDLINE]
5.

The French neurotropic vaccine strain of yellow fever virus accumulates mutations slowly during passage in cell culture.

Holbrook MR, Li L, Suderman MT, Wang H, Barrett AD.

Virus Res. 2000 Aug;69(1):31-9.

PMID:
10989183
[PubMed - indexed for MEDLINE]
6.

Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil.

Galler R, Pugachev KV, Santos CL, Ocran SW, Jabor AV, Rodrigues SG, Marchevsky RS, Freire MS, Almeida LF, Cruz AC, Yamamura AM, Rocco IM, da Rosa ES, Souza LT, Vasconcelos PF, Guirakhoo F, Monath TP.

Virology. 2001 Nov 25;290(2):309-19.

PMID:
11883195
[PubMed - indexed for MEDLINE]
Free Article
7.

Comparison of the genomes of the wild-type French viscerotropic strain of yellow fever virus with its vaccine derivative French neurotropic vaccine.

Wang E, Ryman KD, Jennings AD, Wood DJ, Taffs F, Minor PD, Sanders PG, Barrett AD.

J Gen Virol. 1995 Nov;76 ( Pt 11):2749-55.

PMID:
7595382
[PubMed - indexed for MEDLINE]
Free Article
8.

A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys.

Guirakhoo F, Zhang Z, Myers G, Johnson BW, Pugachev K, Nichols R, Brown N, Levenbook I, Draper K, Cyrek S, Lang J, Fournier C, Barrere B, Delagrave S, Monath TP.

J Virol. 2004 Sep;78(18):9998-10008.

PMID:
15331733
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Genetic stability of a dengue vaccine based on chimeric yellow fever/dengue viruses.

Mantel N, Girerd Y, Geny C, Bernard I, Pontvianne J, Lang J, Barban V.

Vaccine. 2011 Sep 2;29(38):6629-35. doi: 10.1016/j.vaccine.2011.06.101. Epub 2011 Jul 13.

PMID:
21745519
[PubMed - indexed for MEDLINE]
10.

Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil.

Engel AR, Vasconcelos PF, McArthur MA, Barrett AD.

Vaccine. 2006 Apr 5;24(15):2803-9. Epub 2006 Jan 18.

PMID:
16464518
[PubMed - indexed for MEDLINE]
11.

Neurovirulence tests of three 17D yellow fever vaccine strains.

Minor PD.

Biologicals. 2011 May;39(3):167-70. doi: 10.1016/j.biologicals.2011.04.001. Epub 2011 May 4.

PMID:
21536454
[PubMed - indexed for MEDLINE]
12.

Yellow fever 17D vaccine virus isolated from healthy vaccinees accumulates very few mutations.

Xie H, Cass AR, Barrett AD.

Virus Res. 1998 May;55(1):93-9.

PMID:
9712515
[PubMed - indexed for MEDLINE]
13.

High stability of yellow fever 17D-204 vaccine: a 12-year restrospective analysis of large-scale production.

Barban V, Girerd Y, Aguirre M, Gulia S, Pétiard F, Riou P, Barrere B, Lang J.

Vaccine. 2007 Apr 12;25(15):2941-50. Epub 2006 Aug 1.

PMID:
16914238
[PubMed - indexed for MEDLINE]
14.

Mutation in NS5 protein attenuates mouse neurovirulence of yellow fever 17D vaccine virus.

Xie H, Ryman KD, Campbell GA, Barrett AD.

J Gen Virol. 1998 Aug;79 ( Pt 8):1895-9.

PMID:
9714237
[PubMed - indexed for MEDLINE]
Free Article
15.

Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice.

Ryman KD, Ledger TN, Campbell GA, Watowich SJ, Barrett AD.

Virology. 1998 Apr 25;244(1):59-65.

PMID:
9581778
[PubMed - indexed for MEDLINE]
Free Article
16.

Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: infant mice provide an accurate surrogate for the test in monkeys.

Monath TP, Myers GA, Beck RA, Knauber M, Scappaticci K, Pullano T, Archambault WT, Catalan J, Miller C, Zhang ZX, Shin S, Pugachev K, Draper K, Levenbook IS, Guirakhoo F.

Biologicals. 2005 Sep;33(3):131-44.

PMID:
15975826
[PubMed - indexed for MEDLINE]
17.

Neurovirulence of yellow fever 17DD vaccine virus to rhesus monkeys.

Marchevsky RS, Freire MS, Coutinho ES, Galler R.

Virology. 2003 Nov 10;316(1):55-63. Erratum in: Virology. 2004 Jul 20;325(1):165.

PMID:
14599790
[PubMed - indexed for MEDLINE]
Free Article
18.

Adverse events associated with 17D-derived yellow fever vaccination--United States, 2001-2002.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2002 Nov 8;51(44):989-93.

PMID:
12455906
[PubMed - indexed for MEDLINE]
Free Article
19.

[Completed sequences analysis on the Chinese attenuated yellow fever 17D vaccine strain and the WHO standard yellow fever 17D vaccine strain].

Li J, Yu YX, Dong GM.

Zhongguo Yi Miao He Mian Yi. 2009 Apr;15(2):145-51. Chinese.

PMID:
20077661
[PubMed - indexed for MEDLINE]
20.

Pressure-inactivated yellow fever 17DD virus: implications for vaccine development.

Gaspar LP, Mendes YS, Yamamura AM, Almeida LF, Caride E, Gonçalves RB, Silva JL, Oliveira AC, Galler R, Freire MS.

J Virol Methods. 2008 Jun;150(1-2):57-62. doi: 10.1016/j.jviromet.2008.03.002.

PMID:
18420285
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk